AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

HEIGHT-BASED AND CONVENTIONAL SPINAL ANAESTHETIC DOSING IN GERIATRIC PATIENTS

RecruitingNAAges 60 Years - 80 YearsAllShaheed Mohtarma Benazir Bhutto Institue of Trauma
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The goal of this clinical trial is to find out whether height-based dosing of spinal anaesthesia provides better hemodynamic stability and anesthetic outcome than conventional fixed dosing in elderly patients undergoing lower limb orthopaedic surgery.The main questions this study aims to answer are: 1. Does height-based spinal anaesthetic dosing reduce the risk of hypotension and bradycardia during surgery as compared to conventional fixed dosing? 2. Does it improve anaesthetic outcomes, such as the onset and duration of sensory and motor block?

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: Individuals aged 60 to 80 years. Either gender (male or female). Patients who are ASA physical status I-III. Individuals scheduled to undergo elective lower limb orthopaedic surgeries (e.g., fracture fixation, total knee replacement, open reduction and internal fixation). Patients planned to receive spinal anaesthesia as the primary anaesthetic technique. Those who provide informed written consent for participation in the study. Exclusion Criteria: Individuals exhibiting a stature inferior to 150 cm. Patients receiving anti-hypertensive drugs or those on beta blockers or beta-agonists. Patients with a history of neurological disease like CVA or Parkinsonism. Patients presenting with sepsis (โ‰ฅ 2 positive SIRS criteria with positive aseptically obtained blood or wound culture). Patients with a history of coagulation disorders like haemophilia or vWD or those with a history of anti-platelet drug intake in the last 2 weeks. Individuals possessing a documented history of hypersensitivity reactions to pharmacological agents utilized in the research. Patients who will be diagnosed with a skin infection at the spinal needle puncture site. Patients undergoing emergency orthopaedic procedures requiring immediate intervention
๐Ÿ’Š

What it tests

  • Group A : Spinal Anaesthetic Dose
  • Group B : Conventional Dose
๐Ÿ“

Where

1 site
Shaheed Mohtarma Benazir Bhutto Institue of Trauma
Karachi, Pakistan
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy